LTRN
USDLantern Pharma Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$3.260
Máximo
$3.510
Mínimo
$3.020
Volumen
0.09M
Fundamentos de la Empresa
Capitalización de Mercado
36.9M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
0.13M
Bolsa
NCM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Lantern Pharma to Present AI-Driven Cancer Drug Development & Research Platforms at Inaugural AI for Biology and Medicine Symposium at UNT
Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, will both be
Lantern Pharma Presents LP-284 Clinical Data at 25th LL&M Congress, Highlighting Complete Response in Therapeutically Exhausted DLBCL Patient & Therapeutic Potential in Advanced B-Cell Cancers.
AI-advanced drug candidate achieves complete metabolic response after two cycles in patient who failed CAR-T and bispecific antibody therapies, validating LP-284's mechanism of action. A novel differentiated
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2025
Lantern Pharma Inc. (NASDAQ:LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development, today
Acciones Relacionadas
IPI
Intrepid Potash Inc
AUUDW
Auddia Inc. Warrants
RLX
RLX Technology Inc. American Depositary Shares each representing the right to receive one (1) ordinary share
ATNF
180 Life Sciences Corp.
HSY
The Hershey Company
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.